Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease (APOSA-PAD)

This study has been completed.
Sponsor:
Collaborators:
NHS Tayside
British Heart Foundation
Information provided by (Responsible Party):
Alan Robertson, University of Dundee
ClinicalTrials.gov Identifier:
NCT01147705
First received: June 18, 2010
Last updated: July 3, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)